ART™ Platform Pipeline

About Elite Pharmaceuticals

Elite Pharmaceuticals is a specialty pharmaceutical company with a dual-strategy mission: to generate revenue from a portfolio of niche, controlled-release generic drugs while advancing a proprietary pipeline of abuse-deterrent opioid products. The company leverages its in-house cGMP and DEA-registered manufacturing facility and its core competency in complex oral formulations to create products with higher technical barriers to entry. Its long-term strategy hinges on the successful development and regulatory approval of its ART™ platform, aiming to address the critical public health need for safer pain management therapies.

Therapeutic Areas